Market Updates: Osteopore (OSX:ASX)
Osteopore’s price spiked to highs of AS$1.49 during the ASX’s opening on the 2nd of July 2020 following an announcement with Bioplate Inc for distribution of its products to the US markets. The price took a huge spike to AS$1.49 and immediately faced a sharp correction to AS$0.98 the following hour, resulting in ASX calling for a trading halt during the day. Prices were fluctuating between AS$0.80 and AS$0.60 over the next few weeks.
The Company is in discussions with Bioplate to assess future demand following the signing of the US distribution agreement announced.
The Distribution Agreement is potentially highly significant and represents a key strategic milestone in Osteopore’s commercialisation path. The US market is the single largest market for Osteopore’s products globally and this distribution agreement is the Company’s first commercial partnership in the US since the Company’s IPO in 2019.
One of Round Table’s Directors Appointed as a Non-Executive Director of MyFiziq
Round Table is pleased to announce that one of its directors has been appointed as a Non-Executive Director in a globally recognised, globally patented health technology company based in Australia, MyFiziq Limited (MYQ:ASX).
The appointment was announced on 13 July 2020. Read the full press release here.